Long term symptoms from Lyme disease is where the disease Chronic Fatigue Syndrome was first noticed. CFS is on the disease list. IFN-a increases CCR5 expression and in turn CCR5 increases IFN-a expression. Leronlimab will downregulate IFN-a.
Other cytokines that have shown to be elevated and are downregulated by leronlimab - IL1-b, IL-2, IL-2, IL-4, IL-6, IL-10, IL-13, TNF-a, IFN-y, VEGF.
Another disease with no approved drug and an FDA that is ignorant of what leronlimab can do.